This suggests that, whilst the other ligands were retained intracellularly, FGF2 might be a critical driver for promoting cancer progression by affecting cancer cells via autocrine or, in tumor microenvironments, via paracrine signaling similar to that described in pancreatic cancer [38]. The gene discussed is FGF2; the disease is pancreatic neoplasm.